Colin Colby

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

Medicine, Cardiology, Pathology +15

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Angela Dispenzieri, Jerry A. Katzmann, Robert A. Kyle et al. · The Lancet · 2010 · 387 citations · Full text

Medicine, Pathology, Clinical Epidemiology +6

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Shaji Kumar, Angela Dispenzieri, Jerry A. Katzmann et al. · Blood · 2010 · 173 citations

Medicine, Neurology, Pathology +9

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

Celine M. Vachon, Robert A. Kyle, Terry M. Therneau et al. · Blood · 2009 · 152 citations · Full text

Medicine, Genetics, Oncology +5

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population

Angela Dispenzieri, Jerry A. Katzmann, Robert A. Kyle et al. · Mayo Clinic Proceedings · 2012 · 138 citations · Full text

Life Sciences, Immunology, Clinical Immunology +6